Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Orthocell Ltd ( (AU:OCC) ) has provided an announcement.
Orthocell Ltd announced a proposed issue of securities, including options expiring in 2028 and 2029, as part of a placement or other type of issue. This move is likely to impact the company’s financial strategy and market positioning by potentially increasing its capital base, which could be used to further its research and development efforts in regenerative medicine.
The most recent analyst rating on (AU:OCC) stock is a Buy with a A$1.32 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine. The company is known for developing and commercializing cell therapies and collagen medical devices aimed at repairing and regenerating soft tissue injuries.
Average Trading Volume: 883,671
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$325.6M
See more insights into OCC stock on TipRanks’ Stock Analysis page.